Heat Biologics Inc. HTBX, +1.07% disclosed Tuesday in a financial filing that its COVID-19 vaccine candidate had been added to the World Health Organization's "draft landscape" of 41 candidate vaccines. Heat had previously announced that it is developing a vaccine for the novel coronavirus with the University of Miami Miller School of Medicine. The company also recently joined the Alliance for Biosecurity, which may help it "secure government funding to support its rapid development, production, and distribution" of its COVID-19 vaccine, according to Maxim Group analysts. Heat's stock was up 9% in trading on Tuesday and has gained 19% year-to-date, while the S&P 500 SPX, -1.11% has dropped 26%.